China SXT Pharmaceuticals Market Sentiment

Market sentiment signals for China SXT Pharmaceuticals (SXTC): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus— N/A

Short Interest▼ 12.3% short float

Options Flow— N/A

Insider Activity— N/A

Analyst Consensus

—

Options Flow (P/C)

—

Avg Consensus PT

—

Highest Price Target

—

Lowest Price Target

—

Short Interest

12.3%

Rising — Bearish

Insider Activity (30d)

—

Short Interest — % of Float

Insider & Market Activity News

Stocks That Hit 52-Week Lows On Wednesday

Wednesday saw 59 companies set new 52-week lows.

Benzinga Insights

Stocks That Hit 52-Week Lows On Friday

During Friday's session, 149 stocks hit new 52-week lows.

Benzinga Insights

Ten Stocks Trending on Discord for Monday December 5, 2022: TSLA, AAPL, COMS, DBGI, TOPS, TLRY, IOVA, SXTC, UAL, CPHI

Charles Gross

PRO
On October 11, China SXT Pharmaceuticals Received The Funds From Mr. Xiao Who Previously Agreed To Purchase 1,625,798 Shares Of The Company, Par Value $0.08/Share At A Per Share Purchase Price Of $1.35. The Gross Proceeds Were $2,194,827

SXTC As previously disclosed, on September 22, 2022, China SXT Pharmaceuticals, Inc. (the "Company") entered into certain securities purchase agreement (the "SPA") with Zhijun Xiao, a non-affiliate

Benzinga Newsdesk

Stocks That Hit 52-Week Lows On Tuesday

During Tuesday's trading, 505 companies set new 52-week lows.

Benzinga Insights

Stocks That Hit 52-Week Lows On Tuesday

Tuesday morning saw 454 companies set new 52-week lows.

Benzinga Insights

China SXT Pharmaceuticals Inc

ニュース

パートナーシップ

ベンジンガ・グローバル